While TEX14 was previously linked to basal breast tumors [44], we believe our study presents the first report demonstrating its more prevalent expression in Luminal tumors, especially of the more aggressive B subtype, and we are unaware of any publications linking LRGUK to breast tumors in general, nor to Luminal tumors in particular. Here, TEX14 is linked to breast neoplasm.